Skip to content
  • Sunday, 26 July 2026
  • 1:45 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Peek behind the paper | AxioParse: streamlining Axiom Microbiome assay data processing and dataset generation
Biotech & Genetic Research

Peek behind the paper | AxioParse: streamlining Axiom Microbiome assay data processing and dataset generation

Jia Lissa May 13, 2026 0

The Data Deluge in Microbiome Research: A Growing Challenge The field of microbiome research has experienced an explosive growth over…

Read More
Laboratory Automation & Robotics

Closing the information gap: ETH Zürich team integrates function and binding in one drug screening assay

Lana Keisha Apr 29, 2026 0

A groundbreaking innovation from a collaborative team at ETH Zurich and Karolinska Institutet is poised to revolutionize early-stage drug discovery…

Read More
Clinical Diagnostics & Pathology

Doherty Institute Researchers Unveil Groundbreaking Assay Identifying Four STIs and Antibiotic Resistance with Unprecedented Speed and Precision

Reynand Amr Wu Apr 17, 2026 0

Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have announced a significant breakthrough in diagnostic medicine,…

Read More
Laboratory Automation & Robotics

Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening Assay

Lana Keisha Apr 13, 2026 0

In a significant advancement poised to reshape the landscape of pharmaceutical development, a collaborative team from ETH Zürich and the…

Read More
Clinical Diagnostics & Pathology

Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.

Reynand Amr Wu Apr 10, 2026 0

Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…

Read More
Laboratory Automation & Robotics

Closing the Information Gap: ETH Zurich Team Integrates Function and Binding in One Drug Screening Assay

Lana Keisha Apr 5, 2026 0

A pioneering team of researchers from ETH Zurich and Karolinska Institutet has unveiled a groundbreaking cross-linking MALDI mass spectrometry (MS)…

Read More
Clinical Diagnostics & Pathology

Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.

Reynand Amr Wu Apr 1, 2026 0

Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…

Read More
Laboratory Automation & Robotics

Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening Assay

Lana Keisha Mar 29, 2026 0

A groundbreaking development from a collaborative team at ETH Zurich and Karolinska Institutet promises to revolutionize early-stage drug discovery by…

Read More
Clinical Diagnostics & Pathology

Doherty Institute Researchers Unveil Groundbreaking Assay for Rapid, Precise Detection of Four STIs and Antibiotic Resistance

Reynand Amr Wu Mar 25, 2026 0

Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have developed a portable, point-of-care diagnostic tool capable…

Read More
Laboratory Automation & Robotics

Closing the information gap: ETH Zürich team integrates function and binding in one drug screening assay

Lana Keisha Mar 22, 2026 0

A groundbreaking advance in drug discovery, developed by a collaborative team from ETH Zürich and Karolinska Institutet, promises to significantly…

Read More

Posts pagination

1 2
European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian CancerPaternal Age and Genetic Risk: New Research Reveals How Natural Selection in Sperm Favors Disease-Causing MutationsEarly skeleton map reveals how bones form in humansLilly offers up to $3.8 billion for AtaiBeckley in bet on ‘God molecule’ found in toad venom
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ